188 related articles for article (PubMed ID: 13679292)
1. Proton MR spectroscopic imaging in Pelizaeus-Merzbacher disease.
Pizzini F; Fatemi AS; Barker PB; Nagae-Poetscher LM; Horská A; Zimmerman AW; Moser HW; Bibat G; Naidu S
AJNR Am J Neuroradiol; 2003 Sep; 24(8):1683-9. PubMed ID: 13679292
[TBL] [Abstract][Full Text] [Related]
2. Quantitative proton MRS of Pelizaeus-Merzbacher disease: evidence of dys- and hypomyelination.
Hanefeld FA; Brockmann K; Pouwels PJ; Wilken B; Frahm J; Dechent P
Neurology; 2005 Sep; 65(5):701-6. PubMed ID: 16157902
[TBL] [Abstract][Full Text] [Related]
3. [Clinical symptoms and characteristic MR spectroscopic findings in Pelizaeus-Merzbacher disease].
Kurata K; Itoh M; Uchiyama A; Kurano N; Kumada S; Komine M; Tanuma N; Tomita S; Matsui R
No To Hattatsu; 2000 Nov; 32(6):503-8. PubMed ID: 11144164
[TBL] [Abstract][Full Text] [Related]
4. Mutations in the PLP1 gene residue p. Gly198 as the molecular basis of Pelizeaus-Merzbacher phenotype.
Hoffman-Zacharska D; Kmieć T; Poznański J; Jurek M; Bal J
Brain Dev; 2013 Oct; 35(9):877-80. PubMed ID: 23245814
[TBL] [Abstract][Full Text] [Related]
5. Brain N-acetylaspartate is elevated in Pelizaeus-Merzbacher disease with PLP1 duplication.
Takanashi J; Inoue K; Tomita M; Kurihara A; Morita F; Ikehira H; Tanada S; Yoshitome E; Kohno Y
Neurology; 2002 Jan; 58(2):237-41. PubMed ID: 11805250
[TBL] [Abstract][Full Text] [Related]
6. The spectrum of PLP1 gene mutations in patients with the classical form of the Pelizaeus-Merzbacher disease.
Hoffman-Zacharska D; Mierzewska H; Szczepanik E; Poznański J; Mazurczak T; Jakubiuk-Tomaszuk A; Mądry J; Kierdaszuk A; Bal J
Med Wieku Rozwoj; 2013; 17(4):293-300. PubMed ID: 24519770
[TBL] [Abstract][Full Text] [Related]
7. Proton MR spectroscopy in Pelizaeus-Merzbacher disease.
Takanashi J; Sugita K; Osaka H; Ishii M; Niimi H
AJNR Am J Neuroradiol; 1997 Mar; 18(3):533-5. PubMed ID: 9090417
[TBL] [Abstract][Full Text] [Related]
8. A case of complicated spastic paraplegia 2 due to a point mutation in the proteolipid protein 1 gene.
Lee ES; Moon HK; Park YH; Garbern J; Hobson GM
J Neurol Sci; 2004 Sep; 224(1-2):83-7. PubMed ID: 15450775
[TBL] [Abstract][Full Text] [Related]
9. Classification of childhood white matter disorders using proton MR spectroscopic imaging.
Bizzi A; Castelli G; Bugiani M; Barker PB; Herskovits EH; Danesi U; Erbetta A; Moroni I; Farina L; Uziel G
AJNR Am J Neuroradiol; 2008 Aug; 29(7):1270-5. PubMed ID: 18483189
[TBL] [Abstract][Full Text] [Related]
10. Pelizaeus-Merzbacher disease, Pelizaeus-Merzbacher-like disease 1, and related hypomyelinating disorders.
Hobson GM; Garbern JY
Semin Neurol; 2012 Feb; 32(1):62-7. PubMed ID: 22422208
[TBL] [Abstract][Full Text] [Related]
11. MR-revealed myelination in the cerebral corticospinal tract as a marker for Pelizaeus-Merzbacher's disease with proteolipid protein gene duplication.
Takanashi J; Sugita K; Tanabe Y; Nagasawa K; Inoue K; Osaka H; Kohno Y
AJNR Am J Neuroradiol; 1999; 20(10):1822-8. PubMed ID: 10588103
[TBL] [Abstract][Full Text] [Related]
12. The molecular and cellular defects underlying Pelizaeus-Merzbacher disease.
Woodward KJ
Expert Rev Mol Med; 2008 May; 10():e14. PubMed ID: 18485258
[TBL] [Abstract][Full Text] [Related]
13. The magnetic resonance imaging spectrum of Pelizaeus-Merzbacher disease: A multicenter study of 19 patients.
Sumida K; Inoue K; Takanashi J; Sasaki M; Watanabe K; Suzuki M; Kurahashi H; Omata T; Tanaka M; Yokochi K; Iio J; Iyoda K; Kurokawa T; Matsuo M; Sato T; Iwaki A; Osaka H; Kurosawa K; Yamamoto T; Matsumoto N; Maikusa N; Matsuda H; Sato N
Brain Dev; 2016 Jun; 38(6):571-80. PubMed ID: 26774704
[TBL] [Abstract][Full Text] [Related]
14. Pelizaeus-Merzbacher disease in patients with molecularly confirmed diagnosis.
Mierzewska H; Jamroz E; Mazurczak T; Hoffman-Zacharska D; Szczepanik E
Folia Neuropathol; 2016; 54(1):59-65. PubMed ID: 27179222
[TBL] [Abstract][Full Text] [Related]
15. Three or more copies of the proteolipid protein gene PLP1 cause severe Pelizaeus-Merzbacher disease.
Wolf NI; Sistermans EA; Cundall M; Hobson GM; Davis-Williams AP; Palmer R; Stubbs P; Davies S; Endziniene M; Wu Y; Chong WK; Malcolm S; Surtees R; Garbern JY; Woodward KJ
Brain; 2005 Apr; 128(Pt 4):743-51. PubMed ID: 15689360
[TBL] [Abstract][Full Text] [Related]
16. Pelizaeus-Merzbacher disease as a chromosomal disorder.
Yamamoto T; Shimojima K
Congenit Anom (Kyoto); 2013 Mar; 53(1):3-8. PubMed ID: 23480352
[TBL] [Abstract][Full Text] [Related]
17. A novel PLP1 frameshift mutation causing a milder form of Pelizaeus-Merzbacher disease.
Shiihara T; Watanabe M; Moriyama K; Uematsu M; Sameshima K
Brain Dev; 2015 Apr; 37(4):455-8. PubMed ID: 25043250
[TBL] [Abstract][Full Text] [Related]
18. Pelizaeus-Merzbacher disease.
Koeppen AH; Robitaille Y
J Neuropathol Exp Neurol; 2002 Sep; 61(9):747-59. PubMed ID: 12230321
[TBL] [Abstract][Full Text] [Related]
19. Identification of proteolipid protein 1 gene duplication by multiplex ligation-dependent probe amplification: first report of genetically confirmed family of Pelizaeus-Merzbacher disease in Korea.
Kim SJ; Yoon JS; Baek HJ; Suh SI; Bae SY; Cho HJ; Ki CS
J Korean Med Sci; 2008 Apr; 23(2):328-31. PubMed ID: 18437021
[TBL] [Abstract][Full Text] [Related]
20. Clinical and mutational spectrum of Colombian patients with Pelizaeus Merzbacher Disease.
Velasco Parra HM; Maradei Anaya SJ; Acosta Guio JC; Arteaga Diaz CE; Prieto Rivera JC
Colomb Med (Cali); 2018 Jun; 49(2):182-187. PubMed ID: 30104812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
